Association of worse prognosis with an aberrant diurnal cortisol rhythm in patients with advanced lung cancer

Chronobiology International

Volumn 29, Issue 8, 2012, Pages 1109-1120

  Kim, Kyu S ^a   Kim, Young C ^a   Oh, In J ^a   Kim, Sung S ^a   Choi, Jun Y ^b   Ahn, Ryun S ^b  

^a Chonnam National University Research Institute of Medical Sciences   (South Korea)

^b CHA Gangnam Medical Center   (South Korea)

Author keywords

Cortisol awakening response; Diurnal cortisol rhythm; Diurnal cortisol slope; Lung cancer; PS score

Indexed keywords

HYDROCORTISONE;

AGED; ARTICLE; CHEMISTRY; CIRCADIAN RHYTHM; FEMALE; HUMAN; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SALIVA;

AGED; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYDROCORTISONE; LUNG NEOPLASMS; MALE; MIDDLE AGED; SALIVA;

EID: 84866290286     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420528.2012.706767     Document Type: Article

References (76)

1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl. Cancer Inst. 85:365-376. (Pubitemid 23073154)
2. Abercrombie HC, Giese-Davis J, Sephton S, Epel ES, Turner-Cobb JM, Spiegel D. (2004). Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology 29:1082-1092. (Pubitemid 38833536)
3. Adam EK, Kumari M. (2009). Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology 34:1423-1436.
4. Ahn RS, Choi JH, Choi BC, Kim JH, Lee SH, Sung SS. (2011). Cortisol, estradiol-17?, and progesterone secretion within the first hour after awakening in women with regular menstrual cycles. J. Endocrinol. 211:285-295.
5. Baker RW, Walker BR, Shaw RJ, Honour JW, Jessop DS, Lightman SL, Zumla A, Rook GA. (2000). Increased cortisol: cortisone ratio in acute pulmonary tuberculosis.Am. J. Respir.Crit. CareMed. 162:1641-1647.
6. Bernard S, Cajavec Bernard B, Levi F, Herzel H. (2010). Tumor growth rate determines the timing of optimal chronomodulated treatment schedules. PLoS Comput. Biol. 19:e1000712.
7. Bornstein SR, Chrousos GP. (1999). Clinical review 104: adrenocorticotropin (ACTH)-and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J. Clin. Endocrinol. Metab. 84:1729-1736. (Pubitemid 30644284)
8. Bornstein SR, Licinio J, Tauchnitz R, Engelmann L, Negrao AB, Gold P, Chrousos GP. (1998). Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J. Clin. Endocrinol. Metab. 83:280-283. (Pubitemid 28498351)
9. Bower JE, Ganz PA, Dickerson SS, Petersen L, Aziz N, Fahey JL. (2005). Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 30:92-100. (Pubitemid 39195048)
10. Cavadini G, Petrzilka S, Kohler P, Jud C, Tobler I, Birchler T, Fontana A. (2007). TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc. Natl. Acad. Sci. U. S. A. 104:12843-12848. (Pubitemid 47255242)
11. Chida Y, Steptoe A. (2009). Cortisol awakening response and psychosocial factors: a systematic review and meta-analysis. Biol. Psychol. 80:265-278.
12. Cleeland CS. (2007). Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J. Natl. Cancer Inst. Monogr. 37:16-21.
13. Clow A, Hucklebridge F, Stalder T, Evans P, Thorn L. (2010a). The cortisol awakening response: more than a measure of HPA axis function. Neurosci. Biobehav. Rev. 35:97-103.
14. Clow A, Hucklebridge F, Thorn L. (2010b). The cortisol awakening response in context. Int. Rev. Neurobiol. 93:153-175.
15. Dallman MF, Akana SF, Scribner KA, Bradbury MJ, Walker CD, Strack AM, Cascio CS. (1992). Stress, feedback and facilitation in the hypothalamo- pituitary-adrenal axis. J. Neuroendocrinol. 4:517-526.
16. Degner LF, Sloan JA. (1995). Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J. Pain Symptom Manage. 10:423-431.
17. Dekkers JC, Geenen R, Godaert GL, van Doornen LJ, Bijlsma JW. (2000). Diurnal rhythm of salivary cortisol levels in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 43:465-467.
18. Derin D, Soydinç HO, Guney N, Tas F, Camlica H, Duranyildiz D, Yasasever V, Topuz E. (2008). Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer. Lung Cancer 59:240-245. (Pubitemid 351173407)
19. De Vita F, Orditura M, Auriemma A, Infusino S, Catalano G. (1998). Serum concentrations of proinflammatory cytokines in advanced non small cell lung cancer patients. J. Exp. Clin. Cancer Res. 17:413-417. (Pubitemid 29083412)
20. Eismann EA, Lush E, Sephton SE. (2010). Circadian effects in cancerrelevant psychoneuroendocrine and immune pathways. Psychoneuroendocrinology 35:963-976.
21. Federenko I, Wust S, Hellhammer DH, Dechoux R, Kumsta R, Kirschbaum C. (2004). Free cortisol awakening responses are influenced by awakening time. Psychoneuroendocrinology 29:174-184. (Pubitemid 37357177)
22. Fries E, Dettenborn L, Kirschbaum C. (2009). The cortisol awakening response (CAR): facts and future directions. In. J. Psychophysiol. 72:67-73.
23. Gaab J, Baumann S, Budnoik A, Gmúnder H, Hottinger N, Ehlert U. (2005). Reduced reactivity and enhanced negative feedback sensitivity of the hypothalamus-pituitary-adrenal axis in chronic whiplash-associated disorder. Pain 119:219-224. (Pubitemid 41752982)
24. Gerra G, Zaimovic A, Mascetti GG, Gardini S, Zambelli U, Timpano M, Raggi MA, Brambilla F. (2001). Neuroendocrine responses to experimentally-induced psychological stress in healthy humans. Psychoneuroendocrinology 26:91-107.
25. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L; International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. (2007). The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J. Thorac. Oncol. 2:706-714. (Pubitemid 47357522)
26. Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, Spitznagel EL, Piccirillo J. (2006). Changing epidemiology of smallcell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J. Clin. Oncol. 24:4539-4544. (Pubitemid 46630948)
27. Gozansky WS, Lynn JS, Laudenslage ML, Kohrt WM. (2005). Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic-pituitary-adrenal axis activity. Clin. Endocrinol. (Oxf.) 63:336-341. (Pubitemid 41233453)
28. Groschl M, Wagner R, Rauh M, Dorr HG. (2001). Stability of salivary steroids: the influences of storage, food and dental care. Steroids 66:737-741. (Pubitemid 32755770)
29. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, Libby DM, PasmantierMW, Koizumi J, Altorki NK, Smith JP. (1999). Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 354:99-105. (Pubitemid 29313143)
30. Hilakivi-Clarke L, Rowland J, Clarke R, Lippman ME. (1994). Psychosocial factors in the development and progression of breast cancer. Breast Cancer Res. Treat. 29:141-160. (Pubitemid 24112616)
31. Hofstra WA, de Weerd AW. (2008). How to assess circadian rhythm in humans: a review of literature. Epilepsy Behav. 13:438-444.
32. Ishida A, Mutoh T, Ueyama T, Bando H, Masubuchi S, Nakahara D, Tsujimoto G, Okamura H. (2005). Light activates the adrenal gland: timing of gene expression and glucocorticoid release. Cell Metab. 2:297-307.
33. Jerjes WK, Cleare AJ, Wessely S, Wood PJ, Taylor NF. (2005). Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome. J. Affect Disord. 87:299-304. (Pubitemid 41039952)
34. Kaasa S, Malt U, Hagen S,Wist E, Moum T, Kvikstad A. (1993). Psychological distress in cancer patients with advanced disease. Radiother. Oncol. 27:193-197. (Pubitemid 23270043)
35. Knight JM, Avery EF, Janssen I, Powell LH. (2010). Cortisol and depressive symptoms in a population-based cohort of midlife women. Psychosom. Med. 72:855-861.
36. Koyanagi S, Ohdo S. (2002). Alteration of intrinsic biological rhythms during interferon treatment and its possible mechanism. Mol. Pharmacol. 62:1393-1399. (Pubitemid 35403834)
37. Kraemer HC, Giese-Davis J, Yutsis M, OHara R, Neri E, Gallagher-Thompson D, Taylor CB, Spiegel D. (2006). Design decisions to optimize reliability of daytime cortisol slopes in an older population. Am. J. Geriatr. Psychiatry 14:325-333.
38. Kunz-Ebrecht SR, KirschbaumC, Marmot M, Steptoe A. (2004). Differences in cortisol awakening response on work days and weekends in women and men from the Whitehall II cohort. Psychoneuroendocrinology 29:516-528. (Pubitemid 38121606)
39. Lally BE, Urbanic JJ, Blackstock AW, Miller AA, Perry MC. (2007). Small cell lung cancer: have we made any progress over the last 25 years? Oncologist 12:1096-1104. (Pubitemid 350007021)
40. Lassen U, Osterlind K, Hansen M, Dombernowsky P, Bergman B, Hansen HH. (1995). Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years -an analysis of 1,714 consecutive patients. J. Clin. Oncol. 13:1215-1220.
41. Levi F, Okyar A, Dulong S, Innominato PF, Clairambault J. (2010). Circadian timing in cancer treatments. Annu. Rev. Pharmacol. Toxicol. 50:377-421.
42. Maunsell E, Brisson J, Mondor M, Verreault R, Deschcnes L. (2001). Stressful life events and survival after breast cancer. Psychosom. Med. 63:306-315. (Pubitemid 32249956)
43. McCorkle R, Quint-Benoliel J. (1983). Symptom distress, current concerns and mood disturbance after diagnosis of life-threatening disease. Soc. Sci. Med. 17:431-438.
44. McEwen BS. (2002). Sex, stress and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol. Aging 23:921-939. (Pubitemid 35217717)
45. McEwen BS. (2007). Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 87:873-904. (Pubitemid 47086281)
46. Mikhaylova IV, Kuulasmaa T, Jaaskelainen J, Voutilainen R. (2007). Tumor necrosis factor-alpha regulates steroidogenesis, apoptosis, and cell viability in the human adrenocortical cell line NCIH295R. Endocrinology 148:386-392. (Pubitemid 46021471)
47. Mormont MC, Bogdan A, Cormont S, Touitou Y, Levi F. (2002). Cortisol diurnal variation in blood and saliva of patients with metastatic colorectal cancer: relevance for clinical outcome. Anticancer Res. 22:1243-1249. (Pubitemid 34836182)
48. Mormont MC, Hecquet B, Bogdan A, Benavides M, Touitou Y, Levi F. (1998). Non-invasive estimation of the circadian rhythm in serum cortisol in patients with ovarian or colorectal cancer. Int. J. Cancer 78:421-424. (Pubitemid 28481158)
49. Mormont MC, Langouet AM, Claustrat B, Bogdan A, Marion S, Waterhouse J, Touitou Y, Levi F. (2002). Marker rhythms of circadian system function: a study of patients with metastatic colorectal cancer and good performance status. Chronobiol. Int. 19:141-155. (Pubitemid 34310824)
50. Neeck G, Federlin K, Graef V, Rusch D, Schmidt KL. (1990). Adrenal secretion of cortisol in patients with rheumatoid arthritis. J. Rheumatol. 17:24-29. (Pubitemid 20070562)
51. Nesbitt JC, Putnam JB , Walsh GL, Roth JA, Mountain CF. (1995). Survival in early-stage non-small cell lung cancer. Ann. Thorac. Surg. 60:466-472.
52. Oginska H, Fafrowicz M, Golonka K, Marek T, Mojsa-Kaja J, Tucholska K. (2010). Chronotype, sleep loss, and diurnal pattern of salivary cortisol in a stimulated daylong driving. Chronobiol. Int. 27:959-974.
53. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. (1982). Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am. J. Clin. Oncol. 5:649-655. (Pubitemid 13149996)
54. Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol. Int. 27:1911-1929.
55. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. (2003). Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28:916-931. (Pubitemid 36936799)
56. Pruessner JC, Wolf OT, Hellhammer DH, Buske-Kirschbaum A, von Auer K, Jobst S, Kaspers F, Kirschbaum C. (1997). Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 61:2539-2549. (Pubitemid 28035578)
57. Rich T, Innominato PF, Boerner J, Mormont MC, Iacobelli S, Baron B, Jasmin C, Levi F. (2005). Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin. Cancer Res. 11:1757-1764. (Pubitemid 40471837)
58. Riva R, Mork PJ,Westgaard RH, Rø M, Lundberg U. (2010). Fibromyalgia syndrome is associated with hypocortisolism. Int. J. Behav. Med. 17:223-233.
59. Sarna L, Brecht ML. (1997). Dimensions of symptom distress in women with advanced lung cancer: a factor analysis. Heart Lung 26:23-30. (Pubitemid 27044791)
60. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. (2000). Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Natl. Cancer Inst. 92:994-1000. (Pubitemid 30469965)
61. Son GH, Chung S, Choe HK, Kim HD, Baik SM, Lee H, Lee HW, Choi S, Sun W, Kim H, Cho S, Lee KH, Kim K. (2008). Adrenal peripheral clock controls the autonomous circadian rhythm of glucocorticoid by causing rhythmic steroid production. Proc. Natl. Acad. Sci. U. S. A. 105:20970-20975.
62. Spiro SG, Silvestri GA. (2005). One hundred years of lung cancer. Am. J. Respir. Crit. Care Med. 172:523-529. (Pubitemid 41232963)
63. Steptoe A, Siegrist J, Kirschbaum C, Marmot M. (2004). Effort-reward imbalance, over commitment, and measures of cortisol and blood pressure over the working day. Psychosom. Med. 66:323-329. (Pubitemid 38668399)
64. Tas F, Duranyildiz D, Argon A, Oguz H, Camlica H, Yasasever V, Topuz E. (2005). Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer. Med. Oncol. 22:353-358. (Pubitemid 43780291)
65. Tkachenko IV, Jaaskelainen T, Jääskeläinen J, Palvimo JJ, Voutilainen R. (2011). Interleukins 1? and 1? as regulators of steroidogenesis in human NCI-H295R adrenocortical cells. Steroids 76:1103-1115.
66. Touitou Y, Levi F, Bogdan A, Benavides M, Bailleul F, Misset JL. (1995). Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors. J. Cancer Res. Clin. Oncol. 121:181-188.
67. Touitou Y, Bogdan A, Levi F, Benavides M, Auzéby A. (1996). Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: relationships with tumour marker antigens. Br. J. Cancer 74:1248-1252. (Pubitemid 26360114)
68. Turnbull AV, Rivier CL. (1999). Regulation of the hypothalamicpituitary- adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 79:1-71. (Pubitemid 29056948)
69. Ulhóa MA, Marqueze EC, Kantermann T, Skene D, Moreno C. (2011). When does stress end? Evidence of a prolonged stress reaction in shiftworking truck drivers. Chronobiol. Int. 28:810-8189.
70. Vining RF, McGinley RA, Maksvytis JJ, Ho KY. (1983). Salivary cortisol: a better measure of adrenal cortical function than serum cortisol. Ann. Clin. Biochem. 20:329-335. (Pubitemid 14176937)
71. Weinrib AZ, Sephton SE, Degeest K, Penedo F, Bender D, Zimmerman B, Kirschbaum C, Sood AK, Lubaroff DM, Lutgendorf SK. (2010). Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer. Cancer 116:4410-4419.
72. WHO Expert Consultation. (2004). Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157-163.
73. Wirth M, Burch J, Violanit J, Burchfiel C, Fekedulegn D, Andrew M, Zhang H, Miller DB, Hébert JR. Vena JE. (2011). Shiftwork duration and the awakening cortisol response among police offices. Chronobiol. Int. 28:458-470.
74. Wust S, Wolf J, Hellhammer DH, Federenko I, Schommer N, Kirschbaum C. (2000). The cortisol awakening response-normal values and confounds. Noise Health 7:79-88.
75. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. (2001). The prevalence of psychological distress by cancer site. Psychooncology 10:19-28. (Pubitemid 32106774)
76. Zarkovic M, Stefanova E, Ciric J, Penezic Z, Kostic V, Sumarac-Dumanovic M, Macut D, Ivovic MS, Gligorovic PV. (2003). Prolonged psychological stress suppresses cortisol secretion. Clin. Endocrinol. (Oxf.) 59:811-816. (Pubitemid 37491589)